Resveratrol also targets “classical” tumor-promoting pathways, such as PI3K/Akt, STAT3/5, and MAPK, which support glycolysis through the upregulation of glycolytic enzymes and glucose transporters [14,148,157,158,159,160] (Table 3). This evidence concerns the gene AKT1 and neoplasm.